scholarly journals Age-Related Epstein-Barr Virus-Positive Lymphoproliferative Disorders of the Orbit and Maxillary Sinus : A Case Report

2012 ◽  
Vol 52 (3) ◽  
pp. 205-209 ◽  
Author(s):  
Takeki Mitsui ◽  
Momoko Mawatari ◽  
Hiromi Koiso ◽  
Akihiko Yokohama ◽  
Hideki Uchiumi ◽  
...  
2012 ◽  
Vol 6 (1) ◽  
Author(s):  
Shemsedin Sadiku ◽  
Fisnik Kurshumliu ◽  
Xhevdet Krasniqi ◽  
Ahmet Brovina ◽  
Emrush Kryeziu ◽  
...  

2010 ◽  
Vol 57 (2) ◽  
pp. 320-323 ◽  
Author(s):  
Stanislas Nimubona ◽  
Marc Bernard ◽  
Sophie De Guibert ◽  
Hélène Duval ◽  
Sylvie Caulet-Maugendre ◽  
...  

2015 ◽  
Vol 3 (7) ◽  
pp. 531-534 ◽  
Author(s):  
Marco Magalhaes ◽  
Zeina Ghorab ◽  
Julien Morneault ◽  
Josephine Akinfolarin ◽  
Grace Bradley

2015 ◽  
Vol 2015 ◽  
pp. 1-12 ◽  
Author(s):  
Kentaro Kikuchi ◽  
Toshiyuki Ishige ◽  
Fumio Ide ◽  
Yumi Ito ◽  
Ichiro Saito ◽  
...  

Recent research has shown that activation-induced cytidine deaminase (AID) triggers somatic hypermutation and recombination, in turn contributing to lymphomagenesis. Such aberrant AID expression is seen in B-cell leukemia/lymphomas, including Burkitt lymphoma which is associated withc-myctranslocation. Moreover, Epstein-Barr virus (EBV) latent membrane protein-1 (LMP-1) increases genomic instability through early growth transcription response-1 (Egr-1) mediated upregulation of AID in B-cell lymphoma. However, few clinicopathological studies have focused on AID expression in lymphoproliferative disorders (LPDs). Therefore, we conducted an immunohistochemical study to investigate the relationship between AID and LMP-1 expression in LPDs (MTX-/Age-related EBV-associated), including diffuse large B-cell lymphomas (DLBCLs). More intense AID expression was detected in LPDs (89.5%) than in DLBCLs (20.0%), and the expression of LMP-1 and EBER was more intense in LPDs (68.4% and 94.7%) than in DLBCLs (10.0% and 20.0%). Furthermore, stronger Egr-1 expression was found in MTX/Age-EBV-LPDs (83.3%) than in DLBCLs (30.0%). AID expression was significantly constitutively overexpressed in LPDs as compared with DLBCLs. These results suggest that increased AID expression in LPDs may be one of the processes involved in lymphomagenesis, thereby further increasing the survival of genetically destabilized B-cells. AID expression may be a useful indicator for differentiation between LPDs and DLBCLs.


2008 ◽  
Vol 204 (4) ◽  
pp. 267-272 ◽  
Author(s):  
Masaru Kojima ◽  
Yukio Morita ◽  
Naoya Nakamura ◽  
Kazuhiko Shimizu ◽  
Kayoko Murayama ◽  
...  

2008 ◽  
Vol 99 (6) ◽  
pp. 1085-1091 ◽  
Author(s):  
Yoshie Shimoyama ◽  
Kazuhito Yamamoto ◽  
Naoko Asano ◽  
Takashi Oyama ◽  
Tomohiro Kinoshita ◽  
...  

2020 ◽  
Vol 7 ◽  
Author(s):  
Seiji Kakiuchi ◽  
Kimikazu Yakushijin ◽  
Ikumi Takagi ◽  
Junpei Rikitake ◽  
Hiroaki Akiyama ◽  
...  

Immunosuppressants are widely used to treat patients with rheumatoid arthritis (RA), and their adverse effects have been known to cause other iatrogenic immunodeficiency-associated lymphoproliferative disorders (OIIA-LPDs). We report a patient with RA who had been treated with methotrexate (MTX) and tacrolimus (TAC) and who developed whole body lymphadenopathy. We simultaneously confirmed angioimmunoblastic T-cell lymphoma (AITL) through a right cervical lymph node biopsy and Epstein-Barr virus-positive B-cell lymphoproliferative disorder (EBV-positive B-LPD) through a bone marrow examination. After cessation of immunosuppressant therapy, both LPDs completely disappeared. Patients with AITL are occasionally reported to develop B-cell lymphoma through reactivation of the EBV, which leads to clonal expansion in the microenvironment. Immunohistochemistry results revealed that both LPD components were positive for EBV-encoded RNA. Moreover, in this patient, the plasma EBV DNA level was found to be high; therefore, EBV infection was a probable etiology. Synchronous coexistence of AITL and B-LPD as an OIIA-LPD has rarely been reported. This case report is the first to discuss the disappearance of both LPDs on withdrawal of immunosuppressants only. AITL occasionally accompany B-LPD; however, this composite lymphoma comprised AITL and B-LPD, and OIIA-LPDs should not be overlooked.


1996 ◽  
Vol 21 (2) ◽  
pp. 123-126
Author(s):  
U. BALDARI ◽  
A. ASCARI RACCAGNI ◽  
B. CELLI ◽  
M. GIOVANNA RIGHINI

Sign in / Sign up

Export Citation Format

Share Document